159 results on '"Marrouche, Nassir F."'
Search Results
2. Early Remodeling of the Left Atrium Following Catheter Ablation of Atrial Fibrillation
3. Smartphone Atrial Fibrillation Burden During the Blanking Period Predicts Catheter Ablation Outcomes
4. PO-03-120 ABLATION SCAR FORMATION IS SUPERIOR WITH THE KODEX-EPD MAPPING SYSTEM IN PERSISTENT ATRIAL FIBRILLATION PATIENTS
5. PO-01-099 EARLY REMODELING OF THE LEFT ATRIUM FOLLOWING CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION: THE IMPACT OF SUBSTRATE MODIFICATION IN DECAAF II
6. PO-01-199 ABLATION PARAMETERS AS PREDICTORS OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY
7. CE-452780-1 LEFT ATRIAL VOLUME IS THE STRONGEST PREDICTOR OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY
8. PO-02-094 ALL PULMONARY VEIN ISOLATION STRATEGIES ARE EQUALLY EFFECTIVE IN REDUCING THE RECURRENCE OF ATRIAL ARRHYTHMIAS
9. PO-02-168 ONE-YEAR OUTCOMES OF PULMONARY VEIN ISOLATION WITH A NOVEL CRYOBALLOON IN 325 PATIENTS: PRIMARY RESULTS OF THE FROZEN AF TRIAL
10. PO-03-093 EFFECT OF CATHETER ABLATION FOR ATRIAL FIBRILLATION ON LEFT ATRIAL FUNCTION AND LEFT VENTRICULAR DIASTOLIC FILLING
11. PO-01-169 CLINICAL APPLICATION OF A NOVEL 31MM CRYOBALLOON FOR PULMONARY VEIN ISOLATION FOR PAROXYSMAL ATRIAL FIBRILLATION: PROCEDURAL DATA FROM THE FIT ARM OF FROZEN AF
12. PO-01-097 HYPERLIPIDEMIA AS A PREDICTIVE RISK FACTOR OF ATRIAL ARRYTHMIA RECURRENCE FOLLOWING ABLATION: A DECAAF II SUBSTUDY
13. PO-05-200 GENDER DISPARITIES IN MANAGEMENT AND OUTCOMES OF ATRIAL FIBRILLATION IN A MODERN LOUISIANA COHORT
14. PO-03-202 WOMEN TRAINEES IN ELECTROPHYSIOLOGY AND THE EFFECT OF ROLE MODELS
15. CE-452778-4 SKIPPING ABLATION LESIONS DOES NOT AFFECT ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION IN PERSISTENT AF: A DECAAF II SUBSTUDY
16. PO-02-219 MODIFIABLE RISK FACTORS PREDICT THE RECURRENCE OF ARRHYTHMIA AFTER PERSISTENT AF ABLATION: ANALYSIS OF THE DECAAF II STUDY
17. PO-01-218 AFRICAN AMERICAN PATIENTS WITH AF AND OBESITY HAVE HIGHER COMORBIDITIES AND MORTALITY RATES THAN THEIR WHITE COUNTERPARTS
18. EARLIEST RECURRENCE DURING THE BLANKING PERIOD PREDICTS ABLATION OUTCOMES: INSIGHTS FROM DECAAF II
19. ATRIAL FIBRILLATION BURDEN AFTER CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION IS THE SAME REGARDLESS OF HEART FAILURE STATUS
20. LEFT ATRIAL VOLUME AND AGE ARE THE STRONGEST PREDICTORS OF ATRIAL FIBRILLATION BURDEN AFTER PULMONARY VEIN ISOLATION FOR PERSISTENT ATRIAL FIBRILLATION- FINDINGS FROM DECAAF II RANDOMIZED CONTROLLED TRIAL
21. DIRECT ORAL ANTICOAGULANTS ARE AS EFFICACIOUS AS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH CANCER
22. EFFECT OF FIBROSIS REGIONALITY ON ATRIAL FIBRILLATION RECURRENCE
23. REGIONAL CHARACTERISTICS OF THE LEFT ATRIAL WALL IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
24. PATIENTS WHO FAIL ATRIAL FIBRILLATION ABLATION BY TRADITIONAL CRITERIA STILL BENEFIT FROM IMPROVEMENTS IN QUALITY OF LIFE AND CARDIAC REMODELING
25. BASELINE NATRIURETIC PEPTIDES AS A PREDICTOR OF ATRIAL FIBRILLATION RECURRENCE AFTER CONVENTIONAL PULMONARY VEIN ISOLATION IN A NON-HEART FAILURE POPULATION: A SUBANALYSIS FROM DECAAF II
26. PREDICTORS OF IMPROVED QUALITY OF LIFE AFTER CATHETER ABLATION IN AF PATIENTS
27. DECAAF II SUBANALYSIS: RADIOFREQUENCY VS. CRYOBALLOON ABLATION
28. LOW ATRIAL FIBROSIS PERCENTAGE IS ASSOCIATED WITH SIGNIFICANTLY REDUCED ATRIAL FIBRILLATION BURDEN FOLLOWING CATHETER ABLATION
29. DIRECT ORAL ANTICOAGULANTS DECREASE ALL-CAUSE MORTALITY COMPARED TO WARFARIN IN PATIENTS WITH OBESITY AND AF
30. AFRICAN AMERICAN WITH ATRIAL FIBRILLATION (AF) AND HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) ARE AT HIGHER RISK OF MORTALITY
31. COMPLIANCE CHALLENGES IN A LONGITUDINAL COVID-19 COHORT USING WEARABLES FOR CONTINUOUS MONITORING
32. PREDICTORS OF ATRIAL FIBRILLATION BURDEN MEASURED BY A SINGLE LEAD SMARTPHONE ECG DEVICE: A DECAAF-II SUB ANALYSIS
33. PO-696-03 INDEX ATRIAL MYOPATHY CORRELATES WITH ATRIAL FIBRILLATION BURDEN POST ABLATION INDEPENDENT FROM ABLATION-INDUCED SCAR
34. PO-697-05 COMPREHENSIVE EVALUATION OF ATRIAL FIBRILLATION RECURRENCE POST CATHER ABLATION THROUGH TEMPORAL PATTERNS
35. PO-699-03 ISCHEMIC STROKE RISK CORRELATES WITH DEGREE OF LEFT ATRIAL FIBROSIS IN ATRIAL FIBRILLATION PATIENTS
36. PO-689-05 PREDICTORS OF ARRHYTHMIA OCCURRENCE IN HOSPITALIZED COVID-19 PATIENTS
37. PO-703-02 DIGITAL HEALTH DEVICE DEMONSTRATES THE LONG-TERM IMPACT OF COVID-19 ON THE CARDIOVASCULAR AND AUTONOMIC SYSTEM
38. PO-697-04 WORSE ABLATION-INDUCED SCAR FORMATION ON FIBROTIC TISSUE: A SUB ANALYSIS FROM THE DECAAF II
39. PO-624-06 THE DIELECTRIC IMAGING SYSTEM IS SUPERIOR TO FLUOROSCOPY IN PREVENTING ATRIAL FIBRILLATION RECURRENCE AFTER CRYOABLATION
40. BASELINE ATRIAL FIBROSIS IS ASSOCIATED WITH HIGHER ATRIAL FIBRILLATION BURDEN DURING THE BLANKING PERIOD
41. CARDIOVASCULAR COMORBIDITIES PREDISPOSE TO CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19 INFECTION
42. THE UTILITY OF D-DIMERS TO RULE OUT LEFT ATRIAL APPENDAGE THROMBUS: A META-ANALYSIS
43. PERSISTENT ATRIAL FIBRILLATION PATIENTS HAVE HIGHER ATRIAL FIBROSIS AND ARRHYTHMIA RECURRENCE
44. INCREASED ATRIAL FIBROSIS AND ARRHYTHMIA RECURRENCE IN ATRIAL FIBRILLATION PATIENTS WITH CORONARY ARTERY DISEASE
45. AUTOMATED MACHINE LEARNING FRAMEWORK TO PROCESS ELECTRONIC MEDICAL RECORDS FOR CARDIOVASCULAR COMPLICATION RISK ASSESSMENT
46. LOW PT AND APTT PREDICT STROKE RISK IN ATRIAL FIBRILLATION PATIENTS
47. POSTERIOR WALL FIBROSIS IS CORRELATED WITH MORE SEVERE LEFT ATRIAL DYSFUNCTION
48. ANTIARRHYTHMIC DRUG PRESCRIPTION: SOCIO-ECONOMIC DISPARITIES AFFECT MORTALITY AND HOSPITALIZATION
49. PROGRESSION OF CHA2DS2-VASC LEADS TO INCREASED STROKE RISK IN ATRIAL FIBRILLATION
50. B-PO02-070 RACIAL AND SOCIOECONOMIC DISPARITIES IN PATIENTS WITH ATRIAL FIBRILLATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.